A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market. A pharma company’s core mission is to improve patient outcomes. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback